SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001140361-23-021220
Filing Date
2023-04-28
Accepted
2023-04-28 08:01:44
Documents
8
Period of Report
2023-06-08

Document Format Files

Seq Description Document Type Size
1 DEF14A ny20006675x1_def14a.htm DEF 14A 923841
2 logo_pmvpharma.jpg GRAPHIC 55635
3 ny20006675x1_bargraph01.jpg GRAPHIC 140661
4 ny20006675x1_bargraph02.jpg GRAPHIC 119232
5 ny20006675x1_pc01.jpg GRAPHIC 560171
6 ny20006675x1_pc02.jpg GRAPHIC 420188
7 sig_davidhmack.jpg GRAPHIC 15618
8 sig_robertticktin.jpg GRAPHIC 17857
  Complete submission text file 0001140361-23-021220.txt   2754088
Mailing Address 8 CLARKE DRIVE CRANBURY NJ 08512
Business Address 8 CLARKE DRIVE CRANBURY NJ 08512 (609) 642-6664
PMV Pharmaceuticals, Inc. (Filer) CIK: 0001699382 (see all company filings)

IRS No.: 463218129 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-39539 | Film No.: 23860268
SIC: 2834 Pharmaceutical Preparations